CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease Press Trust of India dated 20th December 2022

CMFRI, Library (2022) CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease Press Trust of India dated 20th December 2022. Press Trust of India.

[img]
Preview
Text
Press Trust of India_21-12-2022.pdf

Download (24kB) | Preview
Official URL: https://www.ptinews.com/news/south/cmfri-signs-mou...
Related URLs:

    Abstract

    The Central Marine Fisheries Research Institute (CMFRI) has signed an MoU for the production of Cadalmin LivCure extract, a patent-protected nutraceutical product from seaweeds, to combat non-alcoholic fatty liver disease (NAFLD).

    Item Type: Article
    Subjects: CMFRI News Clippings
    Divisions: Library and Documentation Centre
    Depositing User: Mr. Augustine Sipson N A
    Date Deposited: 26 Dec 2022 04:33
    Last Modified: 26 Dec 2022 04:33
    URI: http://eprints.cmfri.org.in/id/eprint/16550

    Actions (login required)

    View Item View Item